- Home
- PAVM vs SSKN Comparison
PAVM vs SSKN Comparison
Compare PAVM & SSKN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PAVM | SSKN |
|---|---|---|
| Founded | 2014 | 1989 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.5M | 8.9M |
| IPO Year | 2016 | 2005 |
Fundamental Metrics
Financial Performance| Metric | PAVM | SSKN |
|---|---|---|
| Price | $7.24 | $1.34 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $510.00 | $6.00 |
| AVG Volume (30 Days) | 22.1K | ★ 124.8K |
| Earning Date | 11-13-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $29,000.00 | ★ $30,980,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $450.56 | $7.74 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $6.00 | $1.18 |
| 52 Week High | $26.85 | $3.86 |
Technical Indicators
Market Signals| Indicator | PAVM | SSKN |
|---|---|---|
| Relative Strength Index (RSI) | 92.92 | 50.76 |
| Support Level | $0.21 | $1.18 |
| Resistance Level | $9.26 | $1.39 |
| Average True Range (ATR) | 0.44 | 0.10 |
| MACD | 0.85 | 0.02 |
| Stochastic Oscillator | 78.72 | 66.67 |
Price Performance
Historical ComparisonAbout PAVM PAVmed Inc.
PAVmed Inc is a multi-product, commercial-stage medical technology company organized to advance a broad pipeline of medical technologies from concept to commercialization. The company operates in a single segment as a medical technology company, with the following lines of business: Diagnostics, Medical Devices, and Digital Health. Its products are EsoGuard, esocheck, and the Veris Cancer Care Platform.
About SSKN Strata Skin Sciences Inc.
Strata Skin Sciences Inc is a medical technology company engaged in developing and commercializing products for the treatment of dermatological disorders. Its primary products include the XTRAC excimer laser and VTRAC lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions. Its operating segment includes Dermatology Recurring Procedures, which is the key revenue driver and Dermatology Procedures Equipment. The Dermatology Recurring Procedures segment derives its revenues from the usage of its equipment by dermatologists to perform XTRAC procedures. Its Dermatology Procedures Equipment segment generates revenues from the sale of equipment, such as lasers and lamp products. Geographically, it derives a majority of revenue from the United States.